Literature DB >> 30021742

Two for the price of one: emerging carbapenemases in a returning traveller to New York City.

Jaimie Mittal1, Wendy A Szymczak1, Yi Guo1, Michael H Levi1, Liang Chen2, Barry N Kreiswirth2, Paul F Riska1, Priya Nori1.   

Abstract

We report a case of a complex orthopaedic infection in a patient returning to New York City from Bangladesh where he was involved in a serious motor vehicle accident. He developed extensive osteomyelitis with a carbapenem-resistant Klebsiella pneumoniae The isolate was unique due to the coexistence of New Delhi metallo-β-lactamase-1 and Oxacillinase type-181 carbapenemases, which are relatively uncommon in North America and were presumably acquired in Bangladesh. Herein, we explore challenges associated with management of carbapenem-resistant Enterobacteriaceae infections, including limited available data on effective antimicrobial therapy. We also highlight the added value of rapid diagnostic technology in guiding clinical management. Ultimately, the patient required both aggressive surgical management and combination therapy with aztreonam and ceftazidime-avibactam for true source control and favourable clinical outcome. © BMJ Publishing Group Limited [year]. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  bone and joint infections; infections

Mesh:

Substances:

Year:  2018        PMID: 30021742     DOI: 10.1136/bcr-2018-225440

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  In vitro selection of aztreonam/avibactam resistance in dual-carbapenemase-producing Klebsiella pneumoniae.

Authors:  Siqiang Niu; Jie Wei; Chunhong Zou; Kalyan D Chavda; Jingnan Lv; Haifang Zhang; Hong Du; Yi-Wei Tang; Johann D D Pitout; Robert A Bonomo; Barry N Kreiswirth; Liang Chen
Journal:  J Antimicrob Chemother       Date:  2020-03-01       Impact factor: 5.790

Review 2.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

3.  Combination antibiotic therapy for treatment of a patient with infected prosthesis and peri-prosthetic abscess due to Klebsiella pneumoniae harboring New Delhi Metallo (NDM) beta-lactamase.

Authors:  Monica Cespedes Santana; Ting Ting Wong; Carl Urban; Noriel Mariano; Janice Burns; George D Rodriguez; Elan Goldwyn; Nishant Prasad; Sorana Segal-Maurer
Journal:  IDCases       Date:  2022-01-06

4.  Success of ceftazidime-avibactam and aztreonam in combination for a refractory biliary infection with recurrent bacteraemia due to blaIMP-4 carbapenemase-producing Enterobacter hormaechei subsp. oharae.

Authors:  Genevieve McKew; John Merlino; Alicia Beukers; Sebastian van Hal; Thomas Gottlieb
Journal:  Access Microbiol       Date:  2021-08-06

Review 5.  Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians.

Authors:  Luigi Principe; Tommaso Lupia; Lilia Andriani; Floriana Campanile; Davide Carcione; Silvia Corcione; Francesco Giuseppe De Rosa; Roberto Luzzati; Giacomo Stroffolini; Marina Steyde; Giuliana Decorti; Stefano Di Bella
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12

6.  A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam.

Authors:  Zachary A Rubnitz; Victoria N Kunkel; Vickie S Baselski; Nathan A Summers
Journal:  Cureus       Date:  2022-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.